Research & Development

在线avav在线视频东方在线av易方达、华夏等首批六家公募基金公司获转融通资格

發布時間︰

  人們走過她的帳蓬   傳說梅里亞出生的時候,霞光披滿了大雪山,山尖出現了黃金色。在线av   如意,銀屏兩個追隨她來到匈奴的侍女,趕緊扶住了她,眼看著劉陵的彩衣上滲出斑斑血痕,齊齊的流淚道︰“這樣的日子我們還要過多久?”av在线视频   “嘔……嘔……”   只要軍臣單于死了,整件事情就會完美的落幕,不論於單事後如何的憤怒,在大局已定的情況下,了不起打一仗也就是了。东方在线av   這讓雲瑯開始懷疑那些動不動就在曠野上與敵人廝殺超過十天的戰爭範例。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.


Connect? Registries


The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo